EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY 4.0

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study

Leonardo Quarta, Elio Mazzone, Donato Cannoletta, Armando Stabile, Simone Scuderi, Francesco Barletta, Vito Cucchiara, Luigi Nocera, Antony Pellegrino, Daniele Robesti, Riccardo Leni, Paolo Zaurito und 8 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2024-10 · 51 (12) · 3789-3798

DOI: 10.1007/s00259-024-06789-5 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 11.06.2024. Verfasst von Leonardo Quarta und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Inst…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lymphatic Metastasis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate-specific membrane antigen radioguided surgery (PSMA-RGS) might identify lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing extended pelvic lymph node dissection (ePLND). The optimal target-to-background (TtB) ratio to define RGS positivity is still unknown. Materials & methods Ad interim analyses which focused on 30 patients with available pathological information were conducted. All patients underwent preoperative PSMA positron emission tomography (PET). 99m-Technetium-PSMA imaging and surgery ([ 99m Tc]Tc-PSMA-I&S) was administered the day before surgery. In vivo measurements were conducted using an intraoperative gamma probe. Performance characteristics and implications associated with different TtB ratios were assessed.

Results

Overall, 9 (30%) patients had LNI, with 22 (13%) and 80 (11%) positive regions and lymph nodes, respectively. PSMA-RGS showed uptakes in 12 (40%) vs. 7 (23%) vs. 6 (20%) patients for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4. At a per-region level, sensitivity, specificity and accuracy for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4 were 72%, 88% and 87% vs. 54%, 98% and 92% vs. 36%, 99% and 91%. Performing ePLND only in patients with suspicious spots at PSMA PET (n = 7) would have spared 77% ePLNDs at the cost of missing 13% (n = 3) pN1 patients. A TtB ratio ≥ 2 at RGS identified 8 (24%) suspicious areas not detected by PSMA PET, of these 5 (63%) harbored LNI, with one pN1 patient (11%) that would have been missed by PSMA PET. Adoption of a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4, would have allowed to spare 18 (60%) vs. 23 (77%) vs. 24 (80%) ePLNDs missing 2 (11%) vs. 3 (13%) vs. 4 (17%) pN1 patients.

Conclusions

PSMA-RGS using a TtB ratio ≥ 2 to identify suspicious nodes, could allow to spare > 50% ePLNDs and would identify additional pN1 patients compared to PSMA PET and higher TtB ratios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLymphatic MetastasisHumansMaleAgedMiddle AgedProspective StudiesSurgery, Computer-AssistedGlutamate Carboxypeptidase IIOrganotechnetium CompoundsRobotic Surgical ProceduresRadiopharmaceuticalsLymph NodesAntigens, SurfaceAged, 80 and over

Stichwörter der Autor:innen

Lymph node dissectionLymph node metastasesProstate cancerProstate-specific membrane antigenRadioguided surgeryStaging

Substanzen

Glutamate Carboxypeptidase IIOrganotechnetium CompoundsFOLH1 protein, humanRadiopharmaceuticalsAntigens, Surface

Autor:innen und Institutionen

  • Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
  • Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. gandaglia.giorgio@hsr.it.
  • Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy. gandaglia.giorgio@hsr.it.

Förderung

  • Italian Ministry of Health

Zitieren

APA

Quarta, L., Mazzone, E., Cannoletta, D., Stabile, A., Scuderi, S., Barletta, F., Cucchiara, V., Nocera, L., Pellegrino, A., Robesti, D., Leni, R., Zaurito, P., Brembilla, G., De Cobelli, F., Samanes Gajate, A. M., Picchio, M., Chiti, A., Montorsi, F., Briganti, A., & Gandaglia, G. (2024). Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. European Journal of Nuclear Medicine and Molecular Imaging, 51(12), 3789-3798. https://doi.org/10.1007/s00259-024-06789-5

Vancouver

Quarta L, Mazzone E, Cannoletta D, Stabile A, Scuderi S, Barletta F, et al. Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(12):3789-3798. doi:10.1007/s00259-024-06789-5

BibTeX
@article{Quarta2024,
  author = {Quarta, Leonardo and Mazzone, Elio and Cannoletta, Donato and Stabile, Armando and Scuderi, Simone and Barletta, Francesco and Cucchiara, Vito and Nocera, Luigi and Pellegrino, Antony and Robesti, Daniele and Leni, Riccardo and Zaurito, Paolo and Brembilla, Giorgio and De Cobelli, Francesco and Samanes Gajate, Ana Maria and Picchio, Maria and Chiti, Arturo and Montorsi, Francesco and Briganti, Alberto and Gandaglia, Giorgio},
  title = {Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {12},
  pages = {3789--3798},
  doi = {10.1007/s00259-024-06789-5}
}
Kostenlos starten →